Drugmaker Sciwind has closed a $39 million Series B round led by LYFE Capital, while SDIC Unity Capital and Qiming Venture Partners have co-led a Series B round funding in Singular Medical.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
